Related Experiment Videos
Summary
Schizophrenia is associated with elevated levels of protein-bound carbohydrates in serum glycoproteins, including glucose and L-arabinose. These findings suggest potential biomarkers for schizophrenia.
Area of Science:
- Biochemistry
- Clinical Chemistry
- Neuroscience
Background:
- Serum glycoproteins play crucial roles in biological processes.
- Alterations in glycoprotein metabolism are implicated in various diseases, including schizophrenia.
Purpose of the Study:
- To comparatively investigate protein-bound carbohydrate components and glycoprotein fractions in normal subjects and schizophrenic patients.
- To identify specific carbohydrate alterations in serum glycoproteins associated with schizophrenia.
Main Methods:
- Electrophoretic analysis of serum glycoprotein fractions.
- Quantification of individual protein-bound carbohydrate components.
- Gas-liquid chromatography-electron-impact mass spectrometry (g.l.c.-e.i.m.s.) and enzymic reactions for carbohydrate identification.
Main Results:
- Significantly elevated mean concentrations of protein-bound carbohydrate components in schizophrenic patients.
- Increased alpha-2 and beta globulin fractions in electrophoretic patterns of serum glycoproteins from schizophrenics.
- Higher content of glucose and L-arabinose in serum glycoproteins of schizophrenic patients compared to controls.
Conclusions:
- Serum glycoprotein alterations, particularly elevated glucose and L-arabinose, are characteristic of schizophrenia.
- These findings correlate with previously reported elevations in serum glycosaminoglycans in schizophrenics.
- The identified carbohydrate changes may serve as potential diagnostic or prognostic indicators for schizophrenia.